CP and COVID-19: In our present analysis, we could show that levels of both the MASP-1/C1-INH complex, a new biomarker for early lectin pathway activation (described in detail in (46)), and the joint LP/CP marker C4d were increased in more severe cases of COVID-19, indicating activation of the lectin pathway during SARS-CoV-2 infection.